# US 2019/0167842 A1 · Aligned fiber and method of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0167842 A1
- Document ID: US20190167842A1
- Status: Published application
- Kind: A1
- Application number: 16/045,159
- Filed: 2018-07-25
- Published: 2019-06-06
- Earliest claimed: 2013-03-14
- Assignees: LifeNet Health
- Applicants: LifeNet Health
- Inventors: Michael Francis; Roy Ogle
- Web page: https://patentgrep.com/patent/US20190167842A1

## CPC

- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/24: Collagen
- A61L 27/26: Mixtures of macromolecular compounds
- A61L 27/3604: {characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel}
- A61L 27/3633: {Extracellular matrix [ECM]}
- A61L 27/38: {containing added animal cells (organs or tissue containing native cells A61L27/36)}
- A61L 27/383: {Nerve cells, e.g. dendritic cells, Schwann cells}
- A61L 27/56: Porous materials, {e.g. foams or sponges}
- C12N 5/0618: {Cells of the nervous system}
- D01D 5/0076: {characterised by the collecting device, e.g. drum, wheel, endless belt, plate or grid (D01D5/0046 takes precedence)}
- D01D 5/0092: {characterised by the electrical field, e.g. combined with a magnetic fields, using biased or alternating fields}
- A61F 2/08: Muscles; Tendons; Ligaments
- A61F 2240/001: Designing or manufacturing processes
- A61L 2400/12: Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
- C12N 2533/30: Synthetic polymers
- C12N 2533/54: Collagen; Gelatin
- C12N 2533/90: Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- D01D: MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

A scaffold comprising an aligned fiber. Further, a scaffold comprising one or more electrospun fibers wherein a fast Fourier transform (FFT) analysis result of the fibers have adjacent major peaks with about 180° apart from each other. Also, methods for promoting differentiation of stem cells into osteoblasts, chondrocytes, ligament or tendon, the method comprising culturing the cells on the scaffold or aligned fiber in conditions suitable for the cell differentiation.

## Claims

### Claim at position 1

1-24. (canceled)

### Claim 25

A method of treating a tissue defect comprising applying a scaffold comprising one or more electrospun fibers, wherein a fast Fourier transform (FFT) analysis result of the fibers have adjacent major peaks with about 180° apart from each other, and wherein the scaffold is in a form of one or more elongated sheets, to surround the tissue defect.

### Claim 26

A method of treating a tissue defect or gap comprising applying a scaffold comprising one or more electrospun fibers, wherein a fastlourier transform (FFT) analysis result of the fibers have adjacent major peaks with about 180° apart from each other, and wherein the scaffold is in the form of one or more elongated rolls, between the tissue defect or gap.

### Claim 27

A method of cell culture comprising culturing cells on a scaffold comprising one or more electrospun fibers, wherein a fast Fourier transform (FFT) analysis result of the fibers have adjacent major peaks with about 180° apart from each other in conditions suitable for the cell culture.

### Claim 28 (depends on 27)

The method of claim 27, wherein the cells are selected from the group consisting of stem cells, adipose derived stem cells, dental pulp stem cells, fibroblasts, and dorsal root ganglia

### Claim 29 (depends on 27)

The method of claim 27, wherein the cells are dorsal root ganglia.

### Claim 30 (depends on 27)

The method of claim 27, wherein the cells are dorsal root ganglia, and the fibers comprise heart basement membrane extract, heart basement membrane extracellular matrix, placenta basement membrane extract, or placenta basement membrane extracellular matrix.

### Claim 31

A method of promoting differentiation of stem cells into osteoblasts, chondrocytes, ligament or tendon, the method comprising culturing the cells on a scaffold comprising one or more electrospun fibers, wherein a fast Fourier transform (FFT) analysis result of the fibers have adjacent major peaks with about 180° apart from each other in conditions suitable for the cell differentiation,

### Claim 32 (depends on 31)

The method of claim 31, wherein the stem cells are progenitor cells or adult stem cells,

### Claim 33 (depends on 32)

The method of claim 32, wherein the progenitor cells or the adult stem cells are derived or isolated from placenta, bone marrow, adipose tissue, blood vessel, amniotic fluid, synovial fluid, synovial membrane, pericardium, periosteum, dura, peripheral blood, umbilical blood, menstrual blood, baby teeth, nucleus pulposus, brain, skin, hair follicle, intestinal crypt, neural tissue, or muscle.

### Claim 34 (depends on 31)

The method of claim 31, wherein the stem cells are pluripotent stem cells.

### Claim 35 (depends on 34)

The method of claim 34, wherein the stem cells are selected from the group consisting of adipose derived stem cells and dental pulp stem cells.
